197 related articles for article (PubMed ID: 15235072)
1. Quantitation of small-animal (124)I activity distributions using a clinical PET/CT scanner.
González Trotter DE; Manjeshwar RM; Doss M; Shaller C; Robinson MK; Tandon R; Adams GP; Adler LP
J Nucl Med; 2004 Jul; 45(7):1237-44. PubMed ID: 15235072
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI.
Palm S; Enmon RM; Matei C; Kolbert KS; Xu S; Zanzonico PB; Finn RL; Koutcher JA; Larson SM; Sgouros G
J Nucl Med; 2003 Jul; 44(7):1148-55. PubMed ID: 12843231
[TBL] [Abstract][Full Text] [Related]
3. Radiation dose estimates in humans for (11)C-acetate whole-body PET.
Seltzer MA; Jahan SA; Sparks R; Stout DB; Satyamurthy N; Dahlbom M; Phelps ME; Barrio JR
J Nucl Med; 2004 Jul; 45(7):1233-6. PubMed ID: 15235071
[TBL] [Abstract][Full Text] [Related]
4. Effect of motion on tracer activity determination in CT attenuation corrected PET images: a lung phantom study.
Pevsner A; Nehmeh SA; Humm JL; Mageras GS; Erdi YE
Med Phys; 2005 Jul; 32(7):2358-62. PubMed ID: 16121593
[TBL] [Abstract][Full Text] [Related]
5. PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer.
Zanzonico PB; Finn R; Pentlow KS; Erdi Y; Beattie B; Akhurst T; Squire O; Morris M; Scher H; McCarthy T; Welch M; Larson SM; Humm JL
J Nucl Med; 2004 Nov; 45(11):1966-71. PubMed ID: 15534070
[TBL] [Abstract][Full Text] [Related]
6. Imaging characteristics of a 3-dimensional GSO whole-body PET camera.
Surti S; Karp JS
J Nucl Med; 2004 Jun; 45(6):1040-9. PubMed ID: 15181139
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients.
Schöder H; Erdi YE; Chao K; Gonen M; Larson SM; Yeung HW
J Nucl Med; 2004 Apr; 45(4):559-66. PubMed ID: 15073250
[TBL] [Abstract][Full Text] [Related]
8. Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems.
Jentzen W; Weise R; Kupferschläger J; Freudenberg L; Brandau W; Bares R; Burchert W; Bockisch A
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):611-23. PubMed ID: 17929014
[TBL] [Abstract][Full Text] [Related]
9. Collimator selection, acquisition speed, and visual assessment of 131I-tositumomab biodistribution in a phantom model.
Tan HK; Wassenaar RW; Zeng W
J Nucl Med Technol; 2006 Dec; 34(4):224-7. PubMed ID: 17146111
[TBL] [Abstract][Full Text] [Related]
10. Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody.
Robinson MK; Doss M; Shaller C; Narayanan D; Marks JD; Adler LP; González Trotter DE; Adams GP
Cancer Res; 2005 Feb; 65(4):1471-8. PubMed ID: 15735035
[TBL] [Abstract][Full Text] [Related]
11. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
Sundaresan G; Yazaki PJ; Shively JE; Finn RD; Larson SM; Raubitschek AA; Williams LE; Chatziioannou AF; Gambhir SS; Wu AM
J Nucl Med; 2003 Dec; 44(12):1962-9. PubMed ID: 14660722
[TBL] [Abstract][Full Text] [Related]
12. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
Verel I; Visser GW; Boellaard R; Boerman OC; van Eerd J; Snow GB; Lammertsma AA; van Dongen GA
J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484
[TBL] [Abstract][Full Text] [Related]
13. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT.
Nehmeh SA; Erdi YE; Kalaigian H; Kolbert KS; Pan T; Yeung H; Squire O; Sinha A; Larson SM; Humm JL
J Nucl Med; 2003 Dec; 44(12):1940-4. PubMed ID: 14660720
[TBL] [Abstract][Full Text] [Related]
14. A three-dimensional registration method for automated fusion of micro PET-CT-SPECT whole-body images.
Jan ML; Chuang KS; Chen GW; Ni YC; Chen S; Chang CH; Wu J; Lee TW; Fu YK
IEEE Trans Med Imaging; 2005 Jul; 24(7):886-93. PubMed ID: 16011318
[TBL] [Abstract][Full Text] [Related]
15. Segmentation of PET volumes by iterative image thresholding.
Jentzen W; Freudenberg L; Eising EG; Heinze M; Brandau W; Bockisch A
J Nucl Med; 2007 Jan; 48(1):108-14. PubMed ID: 17204706
[TBL] [Abstract][Full Text] [Related]
16. A lesion detection observer study comparing 2-dimensional versus fully 3-dimensional whole-body PET imaging protocols.
Lartizien C; Kinahan PE; Comtat C
J Nucl Med; 2004 Apr; 45(4):714-23. PubMed ID: 15073270
[TBL] [Abstract][Full Text] [Related]
17. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution and radiation dosimetry of the serotonin transporter ligand 11C-DASB determined from human whole-body PET.
Lu JQ; Ichise M; Liow JS; Ghose S; Vines D; Innis RB
J Nucl Med; 2004 Sep; 45(9):1555-9. PubMed ID: 15347724
[TBL] [Abstract][Full Text] [Related]
19. Automated 3-dimensional elastic registration of whole-body PET and CT from separate or combined scanners.
Shekhar R; Walimbe V; Raja S; Zagrodsky V; Kanvinde M; Wu G; Bybel B
J Nucl Med; 2005 Sep; 46(9):1488-96. PubMed ID: 16157532
[TBL] [Abstract][Full Text] [Related]
20. Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography.
Toyama H; Ichise M; Liow JS; Modell KJ; Vines DC; Esaki T; Cook M; Seidel J; Sokoloff L; Green MV; Innis RB
J Nucl Med; 2004 Aug; 45(8):1398-405. PubMed ID: 15299067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
